Looking Ahead to 2025: Setting New Standards in Pharmacy Benefits Management
In 2025, pharmacy benefits will require greater accountability from PBM partners. Plan sponsors are increasingly seeking full visibility into their pharmacy spend and demanding partners who serve their interests first.
At DisclosedRx, we're proud to lead this transformation as a Fiduciary and The Fully Disclosed PBM?, setting the standard for what plan sponsors should expect from their pharmacy benefits management relationship.
The Growing Demand for Full Disclosure
The traditional PBM model, often clouded by complex pricing structures and hidden revenue streams, is rapidly becoming obsolete. Forward-thinking organizations are recognizing that Full Disclosure isn't just a buzzword – it's a fundamental requirement for effective cost management and optimal member care.
As The Fiduciary and The Fully Disclosed PBM?, we're seeing more plan sponsors embrace our model, which includes:
Why 2025 Will Be Different
The coming year represents a pivotal moment in pharmacy benefits management. With specialty drug costs continuing to rise and comprising approximately 45% of plan spend while affecting only 1-2% of members, the need for Full Disclosure has never been more critical.
Our Enhanced Specialty Cost Control programs demonstrate how Full Disclosure drives real results, delivering as much as 75% savings per fill while reducing member copays – often to zero. This approach proves that plan sponsors can provide exceptional benefits while maintaining cost control through genuine partnership with their PBM.
The Call for Industry Evolution
We believe it's time for the entire industry to embrace Full Disclosure. As we look ahead to 2025, we invite other PBMs to join us in adopting practices that put clients and members first:
领英推荐
Our Commitment for 2025 and Beyond
At DisclosedRx, we're reinforcing our commitment to operating as a Fiduciary and The Fully Disclosed PBM?. This isn't just about contractual obligations – it's about fundamentally changing how pharmacy benefits are managed. Our model proves that when you combine a Fiduciary business model and Full Disclosure with innovative programs and 24/7 Member Service, everyone benefits.
The Path Forward
For plan sponsors considering their PBM options in 2025, we encourage you to explore a Fiduciary and The Fully Disclosed PBM? model. Ask your current or prospective PBM these essential questions:
Conclusion
As we move into 2025, the choice is clear: continue with traditional PBM practices or embrace Fiduciary partnership and Full Disclosure. At DisclosedRx, we're proud to lead this transformation, proving that when you combine Fiduciary commitment and Full Disclosure with innovation and exceptional service, you create a model that truly serves the best interests of plans and their members.
The future of pharmacy benefits management lies in Full Disclosure. We invite you to join us in making 2025 the year when Fiduciary partnerships and Full Disclosure becomes the industry standard, not the exception.